Early and midterm results of minimally invasive aortic and mitral valve surgery via right mini-thoracotomy.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 7 11 2019
medline: 8 8 2020
entrez: 7 11 2019
Statut: ppublish

Résumé

There are few reports regarding minimally invasive aortic valve replacement concomitant with mitral valve surgery (MIAMVS). The aim of this study was to evaluate early and midterm MIAMVS results. We reviewed the medical records of 21 consecutive patients (nine females, 43%) who underwent MIAMVS through a right mini-thoracotomy from December 2014 to April 2017. Mean patient age was 73 ± 7.4 years and four (19%) were New York Heart Association Class III or IV. Aortic stenosis and mitral valve insufficiency were the most common pathologies. All patients were followed for a mean period of 30 ± 8.5 months. The types of surgery consisted of aortic valve replacement with mitral valve repair in 11 (52%) patients, and replacement of both aortic and mitral valves in 10 (48%), while a tricuspid valve repair, was performed in four. No conversion to a full sternotomy was necessary in any of the cases. Postoperatively, the median intensive care unit and hospital stays were 4.7 and 11.8 days, respectively, with no in-hospital mortality. Following the initial treatment, all 21 patients were followed for a mean period of 30 ± 8.5 months (14-45 months). All patients returned to NYHA Class I or II following the procedure. During the follow-up period, there was no need for a heart valve reoperation for any of the patients and none showed recurrent mitral regurgitation (>mild), though one died from respiratory failure caused by pneumonia. MIAMVS can be performed via a right mini-thoracotomy, with acceptable early and midterm results expected. This may be a feasible alternative to the standard median sternotomy approach.

Identifiants

pubmed: 31692144
doi: 10.1111/jocs.14313
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-39

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Schmitto JD, Mokashi SA, Cohn LH. Minimally-invasive valve surgery. J Am Coll Cardiol. 2010;56:455-462.
Stolinski J, Plicner D, Grudzien G, et al. A comparison of minimally invasive and standard aortic valve replacement. J Thorac Cardiovasc Surg. 2016;152:1030-1039.
Atik FA, Svensson LG, Blackstone EH, Gillinov AM, Rajeswaran J, Lytle BW. Less invasive versus conventional double-valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg. 2011;141:1461-8.e4.
Pfannmüller B, Davierwala P, Hirnle G, et al. Concomitant tricuspid valve repair in patients with minimally invasive mitral valve surgery. Ann Cardiothorac Surg. 2013;2:758-764.
Mihos CG, Pineda AM, Davila H, Larrauri-Reyes MC, Santana O. Combined mitral and tricuspid valve surgery performed via a right minithoracotomy approach. Innovations (Phila). 2015;10:304-308.
Shimizu H, Endo S, Natsugoe S, et al. Thoracic and cardiovascular surgery in Japan in 2016 Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Surg. 2019;67:377-411.
Lamelas J. Minimally invasive concomitant aortic and mitral valve surgery: the ‘Miami Method’. Ann Cardiothorac Surg. 2015;4:33-37.
Lio A, Miceli A, Ferrarini M, Glauber M. Minimally invasive approach for aortic and mitral valve surgery. Eur J Cardiothorac Surg. 2016;50:1204-1205.
Talwar S, Mathur A, Choudhary SK, Singh R, Kumar AS. Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve replacement. Ann Thorac Surg. 2007;84:1219-1225.

Auteurs

Taisuke Nakayama (T)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Yoshitsugu Nakamura (Y)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Kohei Kanamori (K)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Takahisa Hirano (T)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Miho Kuroda (M)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Shuhei Nishijima (S)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Yujiro Ito (Y)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Ryo Tsuruta (R)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Takaki Hori (T)

Department of Cardiovascular Surgery, Chiba-Nishi General Hospital, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH